)
Dr Helen O'Neill
Founder & CEO,
Hertility Health
Dr O’Neill (MSc, PhD) is CEO and Founder of Hertility, an award-winning women’s health company shaping the future of reproductive healthcare by pioneering unique diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. Hertility provides end-to-end gynaecology care from testing to treatment. Hertility was featured in Forbes as one of ten companies with world-changing potential.
Dr Helen O’Neill is also an Associate Professor in Reproductive and Molecular Genetics at the Institute for Women’s Health, University College London. She has an MSc in Prenatal Genetics and Fetal Medicine, a PhD in Stem Cell Biology and Developmental Genetics from UCL and has spent the last 17 years researching genetics, fertility and women’s health. As a thought leader in reproductive science, she is a TedX speaker, has been interviewed frequently on the BBC, BBC World News, Sky News, the Guardian and was awarded in the Top Twenty Women in Data, 2019 as well as Top 50 Women in European Tech by the Financial Times.
Dr Helen O’Neill is also an Associate Professor in Reproductive and Molecular Genetics at the Institute for Women’s Health, University College London. She has an MSc in Prenatal Genetics and Fetal Medicine, a PhD in Stem Cell Biology and Developmental Genetics from UCL and has spent the last 17 years researching genetics, fertility and women’s health. As a thought leader in reproductive science, she is a TedX speaker, has been interviewed frequently on the BBC, BBC World News, Sky News, the Guardian and was awarded in the Top Twenty Women in Data, 2019 as well as Top 50 Women in European Tech by the Financial Times.
Sessions
-
09-Jun-2025EQL:LoungeBuilding Tech for Impact: The Founders Creating Purpose-Driven Innovation